Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression

Romina Salpini, Luna Colagrossi, Maria Concetta Bellocchi, Matteo Surdo, Christina Becker, Claudia Alteri, Marianna Aragri, Alessandra Ricciardi, Daniele Armenia, Michela Pollicita, Fabiola Di Santo, Luca Carioti, Yoram Louzoun, Claudio Maria Mastroianni, Miriam Lichtner, Maurizio Paoloni, Mariarosaria Esposito, Chiara D'Amore, Aldo Marrone, Massimo MarignaniCesare Sarrecchia, Loredana Sarmati, Massimo Andreoni, Mario Angelico, Jens Verheyen, Carlo Federico Perno, Valentina Svicher

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Hepatitis B virus (HBV) reactivation during immunosuppression can lead to severe acute hepatitis, fulminant liver failure, and death. Here, we investigated hepatitis B surface antigen (HBsAg) genetic features underlying this phenomenon by analyzing 93 patients: 29 developing HBV reactivation and 64 consecutive patients with chronic HBV infection (as control). HBsAg genetic diversity was analyzed by population-based and ultradeep sequencing (UDS). Before HBV reactivation, 51.7% of patients were isolated hepatitis B core antibody (anti-HBc) positive, 31.0% inactive carriers, 6.9% anti-HBc/anti-HBs (hepatitis B surface antibody) positive, 6.9% isolated anti-HBs positive, and 3.4% had an overt HBV infection. Of HBV-reactivated patients, 51.7% were treated with rituximab, 34.5% with different chemotherapeutics, and 13.8% with corticosteroids only for inflammatory diseases. In total, 75.9% of HBV-reactivated patients (vs. 3.1% of control patients; P

Original languageEnglish
Pages (from-to)823-833
Number of pages11
JournalHepatology
Volume61
Issue number3
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Hepatitis B Surface Antigens
Hepatitis B virus
Immunosuppression
Hepatitis B Antibodies
Virus Diseases
Acute Liver Failure
Chronic Hepatitis B
Infection Control
Hepatitis
Adrenal Cortex Hormones
Population

ASJC Scopus subject areas

  • Hepatology
  • Medicine(all)

Cite this

Salpini, R., Colagrossi, L., Bellocchi, M. C., Surdo, M., Becker, C., Alteri, C., ... Svicher, V. (2015). Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. Hepatology, 61(3), 823-833. https://doi.org/10.1002/hep.27604

Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. / Salpini, Romina; Colagrossi, Luna; Bellocchi, Maria Concetta; Surdo, Matteo; Becker, Christina; Alteri, Claudia; Aragri, Marianna; Ricciardi, Alessandra; Armenia, Daniele; Pollicita, Michela; Di Santo, Fabiola; Carioti, Luca; Louzoun, Yoram; Mastroianni, Claudio Maria; Lichtner, Miriam; Paoloni, Maurizio; Esposito, Mariarosaria; D'Amore, Chiara; Marrone, Aldo; Marignani, Massimo; Sarrecchia, Cesare; Sarmati, Loredana; Andreoni, Massimo; Angelico, Mario; Verheyen, Jens; Perno, Carlo Federico; Svicher, Valentina.

In: Hepatology, Vol. 61, No. 3, 01.03.2015, p. 823-833.

Research output: Contribution to journalArticle

Salpini, R, Colagrossi, L, Bellocchi, MC, Surdo, M, Becker, C, Alteri, C, Aragri, M, Ricciardi, A, Armenia, D, Pollicita, M, Di Santo, F, Carioti, L, Louzoun, Y, Mastroianni, CM, Lichtner, M, Paoloni, M, Esposito, M, D'Amore, C, Marrone, A, Marignani, M, Sarrecchia, C, Sarmati, L, Andreoni, M, Angelico, M, Verheyen, J, Perno, CF & Svicher, V 2015, 'Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression', Hepatology, vol. 61, no. 3, pp. 823-833. https://doi.org/10.1002/hep.27604
Salpini, Romina ; Colagrossi, Luna ; Bellocchi, Maria Concetta ; Surdo, Matteo ; Becker, Christina ; Alteri, Claudia ; Aragri, Marianna ; Ricciardi, Alessandra ; Armenia, Daniele ; Pollicita, Michela ; Di Santo, Fabiola ; Carioti, Luca ; Louzoun, Yoram ; Mastroianni, Claudio Maria ; Lichtner, Miriam ; Paoloni, Maurizio ; Esposito, Mariarosaria ; D'Amore, Chiara ; Marrone, Aldo ; Marignani, Massimo ; Sarrecchia, Cesare ; Sarmati, Loredana ; Andreoni, Massimo ; Angelico, Mario ; Verheyen, Jens ; Perno, Carlo Federico ; Svicher, Valentina. / Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. In: Hepatology. 2015 ; Vol. 61, No. 3. pp. 823-833.
@article{3fab51d706de4d3581f23f0e4150083c,
title = "Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression",
abstract = "Hepatitis B virus (HBV) reactivation during immunosuppression can lead to severe acute hepatitis, fulminant liver failure, and death. Here, we investigated hepatitis B surface antigen (HBsAg) genetic features underlying this phenomenon by analyzing 93 patients: 29 developing HBV reactivation and 64 consecutive patients with chronic HBV infection (as control). HBsAg genetic diversity was analyzed by population-based and ultradeep sequencing (UDS). Before HBV reactivation, 51.7{\%} of patients were isolated hepatitis B core antibody (anti-HBc) positive, 31.0{\%} inactive carriers, 6.9{\%} anti-HBc/anti-HBs (hepatitis B surface antibody) positive, 6.9{\%} isolated anti-HBs positive, and 3.4{\%} had an overt HBV infection. Of HBV-reactivated patients, 51.7{\%} were treated with rituximab, 34.5{\%} with different chemotherapeutics, and 13.8{\%} with corticosteroids only for inflammatory diseases. In total, 75.9{\%} of HBV-reactivated patients (vs. 3.1{\%} of control patients; P",
author = "Romina Salpini and Luna Colagrossi and Bellocchi, {Maria Concetta} and Matteo Surdo and Christina Becker and Claudia Alteri and Marianna Aragri and Alessandra Ricciardi and Daniele Armenia and Michela Pollicita and {Di Santo}, Fabiola and Luca Carioti and Yoram Louzoun and Mastroianni, {Claudio Maria} and Miriam Lichtner and Maurizio Paoloni and Mariarosaria Esposito and Chiara D'Amore and Aldo Marrone and Massimo Marignani and Cesare Sarrecchia and Loredana Sarmati and Massimo Andreoni and Mario Angelico and Jens Verheyen and Perno, {Carlo Federico} and Valentina Svicher",
year = "2015",
month = "3",
day = "1",
doi = "10.1002/hep.27604",
language = "English",
volume = "61",
pages = "823--833",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression

AU - Salpini, Romina

AU - Colagrossi, Luna

AU - Bellocchi, Maria Concetta

AU - Surdo, Matteo

AU - Becker, Christina

AU - Alteri, Claudia

AU - Aragri, Marianna

AU - Ricciardi, Alessandra

AU - Armenia, Daniele

AU - Pollicita, Michela

AU - Di Santo, Fabiola

AU - Carioti, Luca

AU - Louzoun, Yoram

AU - Mastroianni, Claudio Maria

AU - Lichtner, Miriam

AU - Paoloni, Maurizio

AU - Esposito, Mariarosaria

AU - D'Amore, Chiara

AU - Marrone, Aldo

AU - Marignani, Massimo

AU - Sarrecchia, Cesare

AU - Sarmati, Loredana

AU - Andreoni, Massimo

AU - Angelico, Mario

AU - Verheyen, Jens

AU - Perno, Carlo Federico

AU - Svicher, Valentina

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Hepatitis B virus (HBV) reactivation during immunosuppression can lead to severe acute hepatitis, fulminant liver failure, and death. Here, we investigated hepatitis B surface antigen (HBsAg) genetic features underlying this phenomenon by analyzing 93 patients: 29 developing HBV reactivation and 64 consecutive patients with chronic HBV infection (as control). HBsAg genetic diversity was analyzed by population-based and ultradeep sequencing (UDS). Before HBV reactivation, 51.7% of patients were isolated hepatitis B core antibody (anti-HBc) positive, 31.0% inactive carriers, 6.9% anti-HBc/anti-HBs (hepatitis B surface antibody) positive, 6.9% isolated anti-HBs positive, and 3.4% had an overt HBV infection. Of HBV-reactivated patients, 51.7% were treated with rituximab, 34.5% with different chemotherapeutics, and 13.8% with corticosteroids only for inflammatory diseases. In total, 75.9% of HBV-reactivated patients (vs. 3.1% of control patients; P

AB - Hepatitis B virus (HBV) reactivation during immunosuppression can lead to severe acute hepatitis, fulminant liver failure, and death. Here, we investigated hepatitis B surface antigen (HBsAg) genetic features underlying this phenomenon by analyzing 93 patients: 29 developing HBV reactivation and 64 consecutive patients with chronic HBV infection (as control). HBsAg genetic diversity was analyzed by population-based and ultradeep sequencing (UDS). Before HBV reactivation, 51.7% of patients were isolated hepatitis B core antibody (anti-HBc) positive, 31.0% inactive carriers, 6.9% anti-HBc/anti-HBs (hepatitis B surface antibody) positive, 6.9% isolated anti-HBs positive, and 3.4% had an overt HBV infection. Of HBV-reactivated patients, 51.7% were treated with rituximab, 34.5% with different chemotherapeutics, and 13.8% with corticosteroids only for inflammatory diseases. In total, 75.9% of HBV-reactivated patients (vs. 3.1% of control patients; P

UR - http://www.scopus.com/inward/record.url?scp=84923516283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923516283&partnerID=8YFLogxK

U2 - 10.1002/hep.27604

DO - 10.1002/hep.27604

M3 - Article

C2 - 25418031

AN - SCOPUS:84923516283

VL - 61

SP - 823

EP - 833

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 3

ER -